Financhill
Back

NovaBay Pharmaceuticals, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
85

NBY
NovaBay Pharmaceuticals, Inc.

Last Price:
$10.57
Seasonality Move:
13.91%
Buy
64

CRSP
CRISPR Therapeutics AG

Last Price:
$57.93
Seasonality Move:
6.67%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY) is a Buy

Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $7.39. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
  • NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
64
CRISPR Therapeutics AG (CRSP) is a Buy

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $58.19. The Score for CRSP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals, Inc.'s stock price today?

  • The NovaBay Pharmaceuticals, Inc. share price today is $7.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $58.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.32 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: 666192 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.49 - 5.39) Buy
Bollinger Bands (100): (0.53 - 3.39) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 57.51 Buy
Chaikin Money Flow: 368373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.75 - 57.59) Buy
Bollinger Bands (100): (52.31 - 65.37) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.63 Buy
20-day SMA: 4.03 Buy
50-day SMA: 2.26 Buy
200-day SMA: 1.28 Buy
8-day EMA: 5.83 Buy
20-day EMA: 4.41 Buy
50-day EMA: 2.84 Buy
200-day EMA: 1.09 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.15 Buy
20-day SMA: 56.02 Buy
50-day SMA: 56.28 Buy
200-day SMA: 51.67 Buy
8-day EMA: 55.43 Buy
20-day EMA: 55.53 Buy
50-day EMA: 56.07 Buy
200-day EMA: 39.1 Buy

NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $0.40 per share.

NovaBay Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):